Noah Goodman's most recent trade in Kymera Therapeutics Inc was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Noah Goodman | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 50,000 | 50,081 | - | 0 | Common Stock |